Document Detail


Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment.
MedLine Citation:
PMID:  7358229     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Granulocyte adherence in 10 of 15 untreated asymptomatic hyperglycemic diabetic outpatients (mean fasting glucose +/- SEM, 289 +/- 16 mg/100 ml) was 62 +/- 7% of control values. After treatment (2--4 wk) with tolazamide (500 mg daily), adherence to the nylon fiber columns employed in this study returned to control levels in the seven patients whose fasting glucose levels fell, (mean, 192 +/- 16 mg/100 ml) and deteriorated in the three in whom fasting hyperglycemia worsened. Results of this study indicate that, even in some mildly diabetic patients, a reduction in granulocyte adherence similar to that found in insulin-dependent diabetics may impair the inflammatory response.
Authors:
J D Bagdade; E Walters
Related Documents :
19162329 - Vanadium treatment of type 2 diabetes: a view to the future.
10359389 - Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2...
3322729 - Postoperative management of diabetes mellitus: steady-state glucose control with bedsid...
11323089 - Safety and efficacy of acarbose in the treatment of type 2 diabetes: data from a 5-year...
14722369 - Csf glucose concentrations in infants with febrile convulsions and the possible effect ...
9773719 - No relationship between carbohydrate intake and effect of acarbose on hba1c or gastroin...
8329659 - Diabetes and atherosclerosis.
19823189 - Design of a family-based lifestyle intervention for youth with type 2 diabetes: the tod...
9543309 - Eating disorders and insulin-dependent diabetes mellitus (iddm): relationships with gly...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Diabetes     Volume:  29     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  1980 Apr 
Date Detail:
Created Date:  1980-05-30     Completed Date:  1980-05-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  309-11     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Adhesion
Diabetes Mellitus / drug therapy,  physiopathology*
Female
Granulocytes / drug effects,  physiology*
Humans
Male
Tolazamide / therapeutic use*
Chemical
Reg. No./Substance:
1156-19-0/Tolazamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  HbA1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose.
Next Document:  Low-birthweight children at early school-age: a longitudinal study.